BBOT (BridgeBio Oncology Therapeutics Inc.) Stock Financials & Earnings

BBOTBridgeBio Oncology Therapeutics Inc.

Mkt Cap$820M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$134M

EPS (TTM)-$2.36

Free Cash Flow (TTM)-$95M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$4K
Q4 23	$0	$0	-$42K
Q1 24	$0	$0	-$15M
Q2 24	$0	$0	-$24M
Q3 24	$0	$0	-$20M
Q4 24	$0	$0	-$22M
Q1 25	$0	$0	-$23M
Q2 25	$0	$0	-$30M
Q3 25	$0	$0	-$49M
Q4 25	$0	-$194K	-$64M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q4 22	—	—	$4K
Q1 24	$13M	$2M	—
Q2 24	$23M	$1M	—
Q3 24	$18M	$2M	—
Q4 24	$20M	$2M	—
Q1 25	$21M	$3M	—
Q2 25	$27M	$3M	—
Q3 25	$35M	$14M	—
Q4 25	$38M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q3 23	$0	$0	$0
Q4 23	$0	$0	$0
Q1 24	$2M	$0	$2M
Q2 24	$2M	$0	$2M
Q3 24	$2M	$0	$2M
Q4 24	$2M	$0	$2M
Q1 25	$963K	$0	$963K
Q2 25	$32M	$100M	$131M
Q3 25	$409M	$60M	$468M
Q4 25	$374M	$52M	$425M

Shares Outstanding

Revenue Per Employee

Revenue / Employee